Skip to main content

Spinal Anesthesia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nordic Pharma
Nordic PharmaFrance - Paris
1 program
Spinal Versus General Anesthesia for Ambulatory AnesthesiaN/A1 trial
Active Trials
NCT02529501Completed595Est. Aug 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Nordic PharmaSpinal Versus General Anesthesia for Ambulatory Anesthesia

Clinical Trials (1)

Total enrollment: 595 patients across 1 trials

NCT02529501Nordic PharmaSpinal Versus General Anesthesia for Ambulatory Anesthesia

Spinal Versus General Anesthesia for Ambulatory Anesthesia

Start: Jul 2015Est. completion: Aug 2016595 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.